glp 1 and liver function Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Therapeutic Mechanisms and Clinical Effects

Materials and Methods This was a single centre retrospective observational study conducted at a Swiss bariatric reference centre

ENERGY WITHOUT THE CRASH: Tap into natures source of energy with 100mg of smooth plant caffeine from yerba mate tea plus adaptogens

The convergence of chronic inflammation, mitochondrial dysfunction and altered protein metabolism makes individuals with metabolic diseases particularly vulnerable to sarcopenia

Companies operating in this space may benefit from reviewing their promotional materials to ensure alignment with FDA expectations

Energy on track

Fiber for digestive regularity and gut balance